Tag: albert-bourla

Pfizer Expects FDA Approval to Vaccinate Children Under 12 by Halloween
Pharma giant Pfizer/BioNTech announced on Thursday that the company is seeking FDA approval for its COVID-19 mRNA vaccine to be administered to children between the ages of five and eleven. The submission comes after new...
Pharmaceutical Companies Making Billions From COVID-19 Booster Shots
The COVID-19 pandemic has already raked in billions of dollars of revenue for vaccine manufacturers. As booster shots get approved worldwide, these companies stand to make even more. In the United States, health officials have...
FDA Approves COVID-19 Boosters for Seniors, People at High Risk; Pfizer Seeks Approval to Vaccinate Children
On Sept. 22, the U.S. Food and Drug Administration (FDA) amended the Emergency Use Authorization (EUA) for the Pfizer COVID-19 vaccine to allow it to be used as a booster shot among certain populations. The...
According to recent reports, the Pfizer-BioNTech coronavirus vaccine is expected to rake in tens of billions of dollars in revenue for years to come.
Pfizer’s COVID-19 Vaccine Drives ‘Tremendous’ Revenue as Adverse Event Reports Increase
Despite hundreds of thousands of adverse event reports, pharmaceutical company Pfizer has revealed plans to continue making its Coronavirus Disease 2019 (COVID-19) vaccines long-term, possibly even offering annual vaccines. Revenues this year are expected to...